StockData
ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC

ABVC BIOPHARMA, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.91−0.01 (-0.86%)

Close on Oct 19, 2026

Market cap
$23.71M
P/E (TTM)
–
Dividend yield
–

ABVC BIOPHARMA, INC. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Abvc Biopharma does not break out revenue by segment, region or product in the tagged data of its filings for this period type.